Expression of Hepatocyte Growth Factor/c-met by RT-PCR in Meningiomas
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Hepatocyte growth factor (HGF) is a potent mitogenic cytokine. C-met protein, which is known to be the HGF receptor has transmembrane tyrosine kinase activity and is encoded by the c-met oncogene. The HGF/c-met signaling pathway may play various roles in the carcinogenesis of various organs. Methods: We examined HGF and c-met mRNA expression by utilizing reverse transcription polymerase chain reaction on 40 surgically resected intracranial meningiomas (25 benign, 10 atypical, and 5 anaplastic cases). Results: An HGF overexpression was detected in 28%, 50%, and 80% of the benign, atypical and anaplastic meningiomas, respectively; a high expression of HGF or the coexpression of HGF/c-met was detected in the high grade meningiomas (the atypical and anaplastic cases, p=0.046, p=0.014). An HGF expression was statistically significant in the recurrent meningiomas (p=0.003), and HGF expression was significantly lower than c-met mRNA expression in benign meningiomas (p=0.034). Conclusions: There was no correlation between histologic subtypes and HGF/c-met expression. Determination of HGF expression can be used as a molecular predictor for recurrence of meningioimas. These results suggest that HGF and c-met expression in meningiomas may be associated with anaplastic progression.
Abstract
Background: Hepatocyte growth factor (HGF) is a potent mitogenic cytokine. C-met protein, which is known to be the HGF receptor has transmembrane tyrosine kinase activity and is encoded by the c-met oncogene. The HGF/c-met signaling pathway may play various roles in the carcinogenesis of various organs. Methods: We examined HGF and c-met mRNA expression by utilizing reverse transcription polymerase chain reaction on 40 surgically resected intracranial meningiomas (25 benign, 10 atypical, and 5 anaplastic cases). Results: An HGF overexpression was detected in 28%, 50%, and 80% of the benign, atypical and anaplastic meningiomas, respectively; a high expression of HGF or the coexpression of HGF/c-met was detected in the high grade meningiomas (the atypical and anaplastic cases, p=0.046, p=0.014). An HGF expression was statistically significant in the recurrent meningiomas (p=0.003), and HGF expression was significantly lower than c-met mRNA expression in benign meningiomas (p=0.034). Conclusions: There was no correlation between histologic subtypes and HGF/c-met expression. Determination of HGF expression can be used as a molecular predictor for recurrence of meningioimas. These results suggest that HGF and c-met expression in meningiomas may be associated with anaplastic progression.
참고문헌 (27)
- Perry A, "Meningiomas, in WHO classification of tumours of the central nervous system. 4th ed", pp.164~172 (2007), IARC Press
- Yamasaki F, "Recurrence of meningiomas", Cancer, 89, pp.1102~1110 (2000)
- Sandberg DI, "MIB-1 staining index of pediatric meningiomas", Neurosurgery, 48, pp.590~595 (2001)
- Cerdá-Nicolás M, "Histopathological and cytogenetic findings in benign, atypical and anaplastic human meningiomas: a study of 60 tumors", J Neurooncol, 47, pp.99~108 (2000)
- Perry A, "Molecular pathogenesis of meningiomas", J Neurooncol, 70, pp.183~202 (2004)
- Perry A, "The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas", Cancer, 82, pp.2262~2269 (1998)
- Weinberg RA, "Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis", Cancer Res, 49, pp.3713~3721 (1989)
- Maulik G, "Role of the hepatocyte growth factor receptor, c-Met, in oncogenesis and potential for therapeutic inhibition", Cytokine Growth Factor Rev, 13, pp.41~59 (2002)
- Rosen EM, "Purified scatter factor stimulates epithelial and vascular endothelial cell migration", Proc Soc Exp Biol Med, 195, pp.34~43 (1990)
- Elliott BE, "The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer", Can J Physiol Pharmacol, 80, pp.91~102 (2002)
- Weidner KM, "The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor", hepatocyte growth factor in epithelial cells, 1993, pp.121, 145~154
- Humphrey PA, "Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma", Am J Pathol, 147, pp.386~396 (1995)
- Di Renzo MF, "Overexpression of the Met", HGF receptor in ovarian cancer, 1994, pp.58, 658~662
- Bussolino F, "Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth", J Cell Biol, 119, pp.629~641 (1992)
- Koochekpour S, "Met and hepatocyte growth factor", scatter factor expression in human gliomas, 1997, pp.57, 5391~5398
- Moriyama T, "Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans", Cancer Lett, 124, pp.149~155 (1998)
- Inoue K, "Overexpression of c-met proto-oncogene associated with chromophilic renal cell carcinoma with papillary growth", Virchows Arch, 433, pp.511~515 (1998)
- Arrieta O, "Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma", Cancer, 94, pp.3210~3218 (2002)
- Moriyama T, "Expression of hepatocyte growth factor", scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (review), 1999, pp.3, 531~536
- Book AA, "Scatter factor", hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability, 1999, pp.833, 173~180
- Martínez-Rumayor A, "Coexpression of hepatocyte growth factor", scatter factor (HGF, Cancer Lett, pp.2004, 213[DOI]
- Lamszus K, "Vascular endothelial growth factor, hepatocyte growth factor", scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy, 2000, pp.46, 938~947
- Kärjä V, "Does protein expression predict recurrence of benign World Health Organization grade I meningioma", Hum Pathol, 41, pp.199~207 (2010)
- receptor) tyrosine kinase block HGF, "SF-induced tumor cell growth and invasion", Mol Cancer Ther, 2, pp.1085~1092 (2003)
- Bowers DC, "Scatter factor", hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways, 2000, pp.60, 4277~4283
- Matsumoto K, "Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4", Proteomics, 8, pp.3360~3370 (2008)
- Guerin C, "Glioma inhibition by HGF", NK2, an antagonist of scatter factor, Biochem Biophys Res Commun, pp.2000, 273[DOI]